The overall pooled evaluation revealed a statistically significant percent reduction in body weight of the retatrutide team when contrasted to the sugar pill group after 36 weeks of therapy, with a general MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide peptide cost</a> revealed that individuals can lose up to a quarter of their body weight in under a year, making it virtually two times as efficient as Ozempic.